Remotely controlled nanoparticles fight tumors

morehere

Lancet Series Takes on Energy, Health

September 15, 2007 issue. morehere

Applied Nanoscience Formulation Tests Successfully Against MRSA

(Nanowerk News) Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN) today announced that it has achieved highly successful test results for its proprietary silver nanoparticle formulation against methicillin resistant Staphylococcus aureus, or MRSA. The challenge produced a >99.99% reduction (4+log) in two minutes when coated on filter media and directly introducing the challenge organism. Testing was conducted at an independent, nationally recognized BSL-3 laboratory.
morehere

Forthcoming conferences and Events organised by the Institute of Nanotechnology (UK)

see here
2007

Nanoparticles for European Industry II

Investing in Medical Nanotechnologies II

One-day Course: ‘What is Nanomedicine?’

Public Debate: Nanomedicine

2008

Nanotechnology for Security and Crime Prevention III

Albert Franks Memorial Lecture: Micro and Nano Technologies for Food

Nanotechnology and Smart Textiles for Industry, Healthcare and Fashion

Nanotechnology: A Contributor to Reducing Animal Experiments?

European Food Safety Agency assessing nanoparticles and cloned meat

more here

Nanoparticle Exposures Happen, Says Expert

morehere

Nanoengineers mine tiny diamonds for drug delivery

Northwestern University researchers have shown that nanodiamonds — much like the carbon structure as that of a sparkling 14 karat diamond but on a much smaller scale — are very effective at delivering chemotherapy drugs to cells without the negative effects associated with current drug delivery agents.
more here

European NanOSH Conference

European NanOSH Conference - Nanotechnologies: A Critical Area in
Occupational Safety and Health
3-5 December 2007, Marina Congress Center, Helsinki, Finland see updates
on programme at http://www.ttl.fi/euronanosh
Deadline for early registration on 15 October 2007

The EuroNanOSH Conference will discuss global safety issues surrounding
nanoparticles and nanotechnologies, in occupational safety and health in
particular; and will provide insight into future actions for assuring
the safety, and thereby the future success of nanotechnologies. The
Conference is arranged by the Finnish Institute of Occupational Health
in collaboration with the TEKES - Finnish Funding Agency for Technology
and Innovation and VTT Technical Research Center in Finland. In
addition, the Conference is supported by the ISPESL - National Institute
for Occupational Safety and Prevention in Italy, and the National
Institute for Occupational Safety and Health in USA.

Welcome to the EuroNanOSH Conference!

EuroNanOSH Secretariat
Finnish Institute of Occupational Health
Leila Ahlström
Topeliuksenkatu 41 a A
FI-00250 Helsinki, Finland
Email: euronanosh@ttl.fi

Nanomedicine, is it the Real Deal?

The Institute of Nanotechnology is organising a public engagement evening ‘Nanomedicine…hype? Or a real revolution in healthcare?’ on the 28th November at the Royal College of Surgeons of London. This free event offers an opportunity to the general public to share their thoughts with industrial leaders, nanotechnologists and politicians.
In the interest of openness and public engagement this panel discussion and public debate, which will be held at the Royal College of Surgeons from 18.30hrs–20.30hrs on 28th November 2007, is free of charge and open to all. Places are limited and, therefore, early registration is recommended. For more information and to register please visit http://www.nano.org.uk/events/ionevents.htm or contact Tiju Joseph, tiju.joseph@nano.org.uk, on +44(0)141 330 8734.

The event is organised in conjunction with the ‘Investing in Medical Nanotechnologies II’, conference and exhibition to be held at the Royal College of Surgeons on the 28th and 29th November 2007, http://nanomednet.org/conference07.

Good, Better, Best: The Human Quest for Enhancement

report of this now online
Summary Report of an Invitational Workshop
Convened by the Scientific Freedom, Responsibility and Law Program
American Association for the Advancement of Science
June 1-2, 2006
more here

BT Eyes Technology Revolution for the Pharma Industry

In a white paper, ‘Pharma Futurology: Joined Up Healthcare, 2016 and beyond’, BT’s pharmaceutical division brings its expertise in connecting people and businesses to create a big-picture outlook for the industry. The research reveals expected technology inspired changes that threaten pharmaceutical companies with isolation from an increasingly patient-centric healthcare community.
morehere

A Nanoparticle Vaccine is Developed

Swiss scientists have created a nanoparticle vaccine that delivers vaccines more effectively, with fewer side effects and at a lower cost.
morehere

new column of mine is out Bionics

seehere

The Nanoparticle Drug Delivery Market Report

here
and excerpts here

US EPA: Pollution Prevention through Nanotechnology Conference-Sept.

Pollution Prevention through Nanotechnology Conference: September 25-26, 2007
more here

World Health Report 2007

was launched on Thursday 23rd August. The full report, presently available
in English, French and Spanish as well as the Overview available in
Arabic, Chinese, English, French, Russian and Spanish, are freely
accessible on the WHO web site at www.who.int/whr

Nanotech Survey OECD countries are examining nanomaterials

A NEW REPORT by the 30-member-nation Organization for Economic Cooperation & Development catalogs the growing number of initiatives under way in industrialized countries to address the health and environmental safety implications of manufactured nanomaterials.
Courtesy of Delina Lyon/Rice University
Risks of nanomaterials are still largely unknown. Shown is Delina Lyon, a Rice University researcher who studies the impact of buckyball aggregates on ecosystems.

The 77-page document summarizes information on current developments provided by delegations that participated in the second meeting of OECD’s Working Party on Manufactured Nanomaterials, held this past April in Berlin.
more here

Helping the carbon nanotube industry avoid mega-mistakes of the past

A new analysis of by-products discharged to the environment during production of carbon nanotubes (CNTs) — expected to become the basis of multibillion-dollar industries in the 21st Century — has identified cancer-causing compounds, air pollutants, and other substances of concern, researchers reported here today at the 234th national meeting of the American Chemical Society.
more here

Nanotechnologies Set to Shake Up and Shake Out Drug Delivery Market

LONDON–(BUSINESS WIRE)–Aug 21, 2007 - A new report from Cientifica Ltd., “The Nanoparticle Drug Delivery Market”, identifies who is positioned to be the “winners” and “losers” in the drug delivery market as new nanoparticles and nanostructured delivery techniques begin replacing existing polymer therapeutics that currently dominate the market.

The report, available at www.cientifica.com, projects that the total market for nanotechnology-enabled drug delivery will rise to $26 billion by 2012 from its current size of $3.39 billion, representing a compound annual growth rate of 37%.

But this is just the beginning; the market could steeply rise after 2012, reaching potentially $220 billion by 2015 for these nano-enabled compounds.
see more here

nanotechnology in sunscreen

1) Report by Friend of the Earth “Nanoparticles and Sunscreens: A Consumer Guide for Avoiding Nano Sunscreens”
see here and and here

2) Nanowerk write up UCSB researcher reacts to report on nanotechnology sunscreen threat
see here
3) Nanoparticles in Your Sunscreen: Too Hot To Handle? at bits.blogs.nytimes
here